A center for managing data and coordination for influenza vaccine innovation.
Official title: Collaborative Influenza Vaccine Innovation Centers STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC)
Funded at Digital Infuzion, INC. · NIH-10672873 · Data updated 2026-11-12
This study is all about helping teams work better together to create new and improved flu vaccines, so patients like you can have better options when it comes time for your flu shot.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Digital Infuzion, INC. NIH-funded |
| Lab location | 1 site (Rockville, UNITED STATES) |
| Project start | September 30, 2019 |
| Project end | September 29, 2026 |
| Funding year | 2022 |
| Award (this year) | $1,513,135 |
| NIH project number | 75N93019C00078-P00008-9999-1 |
| Project ID | NIH-10672873 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals who are at high risk for influenza, such as the elderly, young children, and those with compromised immune systems.
✕Less likely to help
Patients who are not at risk for influenza or those who have already received a flu vaccine may not receive direct benefits from this research.
What this research studies
This research focuses on providing essential statistical and data management support to various centers involved in the development of innovative influenza vaccines. It aims to enhance collaboration among vaccine centers, clinical cores, and manufacturing and toxicology teams. By streamlining data collection and analysis, the project seeks to improve the efficiency and effectiveness of vaccine development processes, ultimately leading to better flu vaccines for patients. Patients may benefit from improved vaccine options resulting from this coordinated effort.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective influenza vaccines, improving patient protection against the flu.
How similar studies have gone: Previous research has shown success in collaborative approaches to vaccine development, indicating that this methodology has the potential for impactful results.
Where this research is happening
-
Digital Infuzion, INC.
Rockville, United States Active
Researchers
- Principal investigator: Bour, Stephan — Digital Infuzion, INC.
- Study coordinator: Bour, Stephan
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Surveillance and preparedness for flu and other respiratory pathogens in Kenya
A US-based research grant aims to improve how Kenya detects and prepares for influenza and other respiratory diseases to protect people there and global health.
-
Enhanced Seasonal Influenza Vaccine Targeting Shared and Variable Viral Antigens
A new DNA-based influenza vaccine approach aims to provide both precise protection against circulating strains and broader defense against unexpected strains.
-
How the immune system responds to flu shots and flu infection
This project looks at how adults' immune systems react after flu shots or when they catch the flu to find why some people get better protection than others.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.